Development of a Cancer Pathway Support Guide for Patients and Carers: A Codesign Project

IF 1.8 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES European Journal of Cancer Care Pub Date : 2024-02-02 DOI:10.1155/2024/3623136
Afsana Bhuiya, Sharon Cavanagh, Catherine Nestor, Maria Fomina, Ihsan Ahmed, Christian Von Wagner, Yasemin Hirst
{"title":"Development of a Cancer Pathway Support Guide for Patients and Carers: A Codesign Project","authors":"Afsana Bhuiya,&nbsp;Sharon Cavanagh,&nbsp;Catherine Nestor,&nbsp;Maria Fomina,&nbsp;Ihsan Ahmed,&nbsp;Christian Von Wagner,&nbsp;Yasemin Hirst","doi":"10.1155/2024/3623136","DOIUrl":null,"url":null,"abstract":"<p><i>Background</i>. Cancer diagnosis is a complex and multifaceted process that can be stressful and anxiety-provoking for patients. Evidence-based tools and information aids that can be used for guiding and supporting patients during cancer investigations and after diagnosis are limited. This paper presents a user-centred codesign project that aims to develop a cancer pathway support tool for patients, carers, and healthcare professionals. <i>Method</i>. A mixed-method codesign approach was used including prototype development (January–March 2022), three online codesign workshops (April–June 2022), one-to-one feedback, and beta testing informed by the standardised Theoretical Framework of Acceptability (TFA) questionnaire (July–October 2022). Nine individuals with lived experience of cancer contributed to the project and are referred to as codesigners. <i>Results</i>. The codesigners valued the potential importance of a tool that can be used by the patients and carers if they want specific information about cancer investigations, diagnosis, and treatment. The ability to select what they need as opposed to long leaflets and generating their own questions for the healthcare providers were highlighted as important aspects of improving patient care. The tool was collectively designed to provide clear definitions of the cancer care pathway and easily accessible links from trusted resources and includes practical information to minimise the burden that can be experienced from preparation for appointments and tests. Beta testing results with a small sample of potential users including patients, carers, and healthcare providers (<i>n</i> = 23) showed high acceptability of the guide (range = 7–35, mean = 28.52, and standard deviation = 3.88) based on the TFA questionnaire. <i>Conclusion</i>. A cancer pathway support tool called “Your Cancer Pathway Support Guide (YCPSG)” was developed as a result of an iterative codesign process aiming to improve patient experience and outcomes for people referred on a suspected cancer pathway or who have been diagnosed with cancer. The tool provides information and support in both digital and PDF formats. Further studies are needed to evaluate the potential impact of “Your Cancer Pathway Support Guide” on patient outcomes and experience and the wider system.</p>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2024 1","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer Care","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/3623136","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background. Cancer diagnosis is a complex and multifaceted process that can be stressful and anxiety-provoking for patients. Evidence-based tools and information aids that can be used for guiding and supporting patients during cancer investigations and after diagnosis are limited. This paper presents a user-centred codesign project that aims to develop a cancer pathway support tool for patients, carers, and healthcare professionals. Method. A mixed-method codesign approach was used including prototype development (January–March 2022), three online codesign workshops (April–June 2022), one-to-one feedback, and beta testing informed by the standardised Theoretical Framework of Acceptability (TFA) questionnaire (July–October 2022). Nine individuals with lived experience of cancer contributed to the project and are referred to as codesigners. Results. The codesigners valued the potential importance of a tool that can be used by the patients and carers if they want specific information about cancer investigations, diagnosis, and treatment. The ability to select what they need as opposed to long leaflets and generating their own questions for the healthcare providers were highlighted as important aspects of improving patient care. The tool was collectively designed to provide clear definitions of the cancer care pathway and easily accessible links from trusted resources and includes practical information to minimise the burden that can be experienced from preparation for appointments and tests. Beta testing results with a small sample of potential users including patients, carers, and healthcare providers (n = 23) showed high acceptability of the guide (range = 7–35, mean = 28.52, and standard deviation = 3.88) based on the TFA questionnaire. Conclusion. A cancer pathway support tool called “Your Cancer Pathway Support Guide (YCPSG)” was developed as a result of an iterative codesign process aiming to improve patient experience and outcomes for people referred on a suspected cancer pathway or who have been diagnosed with cancer. The tool provides information and support in both digital and PDF formats. Further studies are needed to evaluate the potential impact of “Your Cancer Pathway Support Guide” on patient outcomes and experience and the wider system.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为患者和照护者制定癌症路径支持指南:协同设计项目
背景。癌症诊断是一个复杂而多方面的过程,可能会给患者带来压力和焦虑。在癌症检查期间和诊断后,可用于指导和支持患者的循证工具和信息辅助工具非常有限。本文介绍了一个以用户为中心的代码设计项目,旨在为患者、护理人员和医疗保健专业人员开发一种癌症路径支持工具。方法。采用混合方法进行代码设计,包括原型开发(2022 年 1 月至 3 月)、三次在线代码设计研讨会(2022 年 4 月至 6 月)、一对一反馈,以及根据标准化可接受性理论框架(TFA)问卷进行 beta 测试(2022 年 7 月至 10 月)。九名有癌症生活经历的个人参与了该项目,他们被称为编码设计者。结果。编码设计者认为,如果患者和护理者需要有关癌症检查、诊断和治疗的具体信息,他们可以使用这种工具。与冗长的传单相比,他们能够选择自己需要的信息,并向医疗服务提供者提出自己的问题,这些都是改善患者护理的重要方面。该工具的集体设计旨在提供癌症护理路径的明确定义和可信资源的便捷链接,并包含实用信息,以最大限度地减轻患者在准备预约和检查时可能遇到的负担。对包括患者、护理人员和医疗服务提供者在内的少量潜在用户(n = 23)进行的 Beta 测试结果显示,根据 TFA 问卷调查,该指南的可接受性很高(范围 = 7-35,平均值 = 28.52,标准差 = 3.88)。结论癌症路径支持工具 "您的癌症路径支持指南(YCPSG)"是迭代编码设计流程的成果,旨在改善疑似癌症路径转诊患者或已确诊癌症患者的患者体验和治疗效果。该工具以数字和 PDF 两种格式提供信息和支持。需要开展进一步研究,以评估 "您的癌症治疗路径支持指南 "对患者治疗效果和体验以及更广泛系统的潜在影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Cancer Care
European Journal of Cancer Care 医学-康复医学
CiteScore
4.00
自引率
4.80%
发文量
213
审稿时长
3 months
期刊介绍: The European Journal of Cancer Care aims to encourage comprehensive, multiprofessional cancer care across Europe and internationally. It publishes original research reports, literature reviews, guest editorials, letters to the Editor and special features on current issues affecting the care of cancer patients. The Editor welcomes contributions which result from team working or collaboration between different health and social care providers, service users, patient groups and the voluntary sector in the areas of: - Primary, secondary and tertiary care for cancer patients - Multidisciplinary and service-user involvement in cancer care - Rehabilitation, supportive, palliative and end of life care for cancer patients - Policy, service development and healthcare evaluation in cancer care - Psychosocial interventions for patients and family members - International perspectives on cancer care
期刊最新文献
Comparison of Nobiletin and 5-Demethylnobiletin as Cancer Chemopreventive Agents The Relationship Between Upper-Limb Lymphedema and Fatigue Among Breast Cancer Survivors Development Process of a Holistic Assessment Questionnaire to Measure and Monitor Cancer-Related Fatigue Faecal Immunochemical Testing in Symptomatic Primary Care Patients: A Diagnostic Accuracy Study Ferroptosis-Related LncRNA BCRP3 Promotes the Proliferation and Migration of Prostate Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1